IMMUNOCHEMOTHERAPY WITH OBINUTUZUMAB OR RITUXIMAB IN a...

Hematological Oncology 2017 / 06 Vol. 35

IMMUNOCHEMOTHERAPY WITH OBINUTUZUMAB OR RITUXIMAB IN a SUBSET OF PATIENTS IN THE RANDOMISED GALLIUM TRIAL WITH PREVIOUSLY UNTREATED MARGINAL ZONE LYMPHOMA (MZL)

Herold, M., Hoster, E., Janssens, A., McCarthy, H., Tedeschi, A., Pocock, C., Rosta, A., Schmidt, P., Trněný, M., Burciu, A., Fingerle-Rowson, G., Rufibach, K., Zeuner, H., Hiddemann, W., Marcus, R.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
35
Language:
english
Journal:
Hematological Oncology
DOI:
10.1002/hon.2437_136
Date:
June, 2017
File:
PDF, 92 KB
english, 2017
Conversion to is in progress
Conversion to is failed